Featured Research

from universities, journals, and other organizations

New role for vascular endothelial growth factor (VEGF) in regulating skin cancer stem cells

Date:
October 20, 2011
Source:
VIB (the Flanders Institute for Biotechnology)
Summary:
In a new study, researchers identify a new role for vascular endothelial growth factor (VEGF) in regulating skin cancer stem cells. The results could have important implications for the prevention and treatment of different epithelial cancers.

In a study published in Nature, researchers identify a new role for vascular endothelial growth factor (VEGF) in regulating skin cancer stem cells. The study was lead by Cédric Blanpain, Welbio investigator at Université Libre de Bruxelles, in collaboration with the groups of Peter Carmeliet (VIB/K.U.Leuven) and Jody J. Haigh (VIB/UGent). The results could have important implications for the prevention and treatment of different epithelial cancers.

Related Articles


Skin squamous cell carcinomas are amongst the most frequent cancers in humans. Recent studies suggest that skin squamous cell carcinoma, like many other human cancers, contain particular cancer cells, known as cancer stem cells, that present increased self-renewal potential that sustain tumor growth. Little is known about the mechanisms that regulate cancer stem cell functions.

High level of VEGF expression in skin cancer stem cells

To dissect the mechanisms that regulate cancer stem cells, the researchers determined which genes are preferentially expressed by cancer stem cell of skin tumors. They found that VEGF, a molecule known to regulate the formation of new vessels, is expressed at high level by skin cancer stem cells, which are located in close contact to the blood vessels. Administration of an antibody that decreases new blood vessel formation to mice presenting skin tumors results in a reduction of the pool of cancer stem cells leading to a reduction of the tumor size, demonstrating that vascular cells regulate skin cancer stem cell functions.

To determine whether VEGF secretion by cancer stem cells directly regulates the function of cancer stem cells, the authors genetically removed VEGF specifically in tumour cells, and found that upon VEGF ablation, skin cancer stem cells are rapidly lost due to a defect in their renewal properties, leading to tumor regression.

"It was extremely exciting to see the complete disappearance of these tumors only two weeks after the treatment" said Benjamin Beck, the first author of the Nature paper.

Critical role for Neuropilin 1, a VEGF receptor

The authors also found that Neuropilin 1, a VEGF receptor, is also highly expressed by skin cancer stem cells, and showed that Neuropilin 1 expression by cancer stem cells is critical to promote cancer stem cell renewal and tumor growth. In addition, the authors found that Neuropilin 1 is also essential for tumor formation, demonstrating the critical role of Neuropilin 1 during both cancer initiation and tumor growth.

Altogether this new study provides novel and important insights into the mechanisms by which VEGF controls tumor growth. VEGF signalling in endothelial cells is critical to sustain the formation of the vascular niche, promoting indirectly the renewal of skin cancer stem cells. VEGF secretion by cancer stem cells acts also directly on cancer stem cells by a Neuropilin 1 dependent mechanism to promote cancer stem cell renewal and tumor growth.

"Anti-VEGF therapies are currently used to treat cancers. These new results have important implications for the prevention and treatment of different epithelial cancers, as new therapies blocking VEGF and/or Neuropilin 1 functions in cancer cells may be more effective for the treatment of certain cancers compared to the therapeutic strategies blocking VEGF function only in endothelial cells" said Cédric Blanpain, the senior and corresponding author of the Nature paper.

Collaboration between Flemish and Walloon academic institutions (VIB, K.U.Leuven, UGent, ULB, FNRS, Welbio

This work is also an example of an effective collaboration between Walloon (ULB, FNRS, Welbio) and Flemish Universities (VIB-K.U.Leuven and VIB-UGhent).

"This collaboration nicely illustrates the great strength of a national collaboration mixing the different and unique expertises of the different Belgian groups with the same and unique goal of better understanding and treating cancer." said Peter Carmeliet (VIB-K.U.Leuven), co-author of the paper.

In conclusion, this new study, published in the online early edition of Nature, identifies a dual role for VEGF in regulating skin cancer stem cells and tumor progression.

Funding

This work was supported by the FNRS, TELEVIE, the Programme d'excellence CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer, the ULB Fondation, the Fond Gaston Ithier.


Story Source:

The above story is based on materials provided by VIB (the Flanders Institute for Biotechnology). Note: Materials may be edited for content and length.


Journal Reference:

  1. Benjamin Beck, Gregory Driessens, Steven Goossens, Khalil Kass Youssef, Anna Kuchnio, Amélie Caauwe, Panagiota A. Sotiropoulou, Sonja Loges, Gaelle Lapouge, Aurélie Candi, Guilhem Mascre, Benjamin Drogat, Sophie Dekoninck, Jody J. Haigh, Peter Carmeliet, Cédric Blanpain. A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours. Nature, 2011; 478 (7369): 399 DOI: 10.1038/nature10525

Cite This Page:

VIB (the Flanders Institute for Biotechnology). "New role for vascular endothelial growth factor (VEGF) in regulating skin cancer stem cells." ScienceDaily. ScienceDaily, 20 October 2011. <www.sciencedaily.com/releases/2011/10/111020024331.htm>.
VIB (the Flanders Institute for Biotechnology). (2011, October 20). New role for vascular endothelial growth factor (VEGF) in regulating skin cancer stem cells. ScienceDaily. Retrieved November 26, 2014 from www.sciencedaily.com/releases/2011/10/111020024331.htm
VIB (the Flanders Institute for Biotechnology). "New role for vascular endothelial growth factor (VEGF) in regulating skin cancer stem cells." ScienceDaily. www.sciencedaily.com/releases/2011/10/111020024331.htm (accessed November 26, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, November 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) — Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins